Designing epitope-focused vaccines via antigen reorientation
Xu, D.; Li, C.; Utz, A.; Weidenbacher, P. A. B.; Tang, S.; Sanyal, M.; Pulendran, B.; Kim, P. S.
Show abstract
A major challenge in vaccine development, especially against rapidly evolving viruses, is the ability to focus the immune response toward evolutionarily conserved antigenic regions to confer broad protection. For example, while many broadly neutralizing antibodies against influenza have been found to target the highly conserved stem region of hemagglutinin (HA-stem), the immune response to seasonal influenza vaccines is predominantly directed to the immunodominant but variable head region (HA-head), leading to narrow-spectrum efficacy. Here, we first introduce an approach to controlling antigen orientation based on the site-specific insertion of short stretches of aspartate residues (oligoD) that facilitates antigen-binding to alum adjuvants. We demonstrate the generalizability of this approach to antigens from the Ebola virus, SARS-CoV-2, and influenza and observe enhanced antibody responses following immunization in all cases. Next, we use this approach to reorient HA in an "upside down" configuration, which we envision increases HA-stem exposure, therefore also improving its immunogenicity compared to HA-head. When applied to HA of H2N2 A/Japan/305/1957, the reoriented H2 HA (reoH2HA) on alum induced a stem-directed antibody response that cross-reacted with both group 1 and 2 influenza A HAs. Our results demonstrate the possibility and benefits of antigen reorientation via oligoD insertion, which represents a generalizable immunofocusing approach readily applicable for designing epitope-focused vaccine candidates. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=83 SRC="FIGDIR/small/521291v1_ufig1.gif" ALT="Figure 1"> View larger version (19K): org.highwire.dtl.DTLVardef@185f949org.highwire.dtl.DTLVardef@b132a9org.highwire.dtl.DTLVardef@174fcc8org.highwire.dtl.DTLVardef@17fb872_HPS_FORMAT_FIGEXP M_FIG C_FIG Seasonal influenza vaccines induce a biased antibody response against the variable head of hemagglutinin, whereas conserved epitopes on the stem are a target for universal vaccines. Here we show that reorienting HA in an "upside-down" configuration sterically occludes the head and redirects the antibody response to the more exposed stem, thereby inducing broad cross-reactivity against hemagglutinins from diverse influenza strains.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines 98%
- Structural Convergence and Water-Mediated Substrate Mimicry Enable Broad Neuraminidase Inhibition by Human Antibodies 97%
- Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes 97%
Similar papers in this journal
- DNA origami vaccines program antigen-focused germinal centers 96%
- Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 prime-boost vaccination 96%
- Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma 96%
Similar papers in this journal
- Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals 97%
- Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants 97%
- Analysis of the Diverse Antigenic Landscape of the Malaria Invasion Protein RH5 Identifies a Potent Vaccine-Induced Human Public Antibody Clonotype 96%
Similar papers in this journal
- Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals 97%
- Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variants 97%
- Polyclonal epitope cartography reveals the temporal dynamics and diversity of human antibody responses to H5N1 vaccination 97%
Similar papers in this journal
- Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants 96%
- Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease 96%
- Permanent lymphocyte subset elimination upon a single dose of AAV-delivered depletion antibody dissects immune control of chronic viral infection 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.